| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/14/2004 | EP1436011A2 Dendrimers for use in targeted delivery |
| 07/14/2004 | EP1436008A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 07/14/2004 | EP1436005A1 Inhibition of neonatal hyperbilirubinemia in breast fed infants |
| 07/14/2004 | EP1436003A2 Taci-immunoglobulin fusion proteins |
| 07/14/2004 | EP1435999A1 Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
| 07/14/2004 | EP1435998A1 Method for treating hepatitis c virus infection in treatment failure patients |
| 07/14/2004 | EP1435997A1 Method for treating hepatitis c virus infection in treatment failure patients |
| 07/14/2004 | EP1435996A2 Compositions comprising mixtures of therapeutic proteins and methods of producing the same |
| 07/14/2004 | EP1435995A2 Composition and method for treating diabetes |
| 07/14/2004 | EP1435994A2 Novel use of pulmonary surfactant |
| 07/14/2004 | EP1435993A2 Utilisation d'une proteine de la famille des crmps pour le traitement des maladies liees au systeme immunitaire |
| 07/14/2004 | EP1435992A2 Chemokines as adjuvants of immune response |
| 07/14/2004 | EP1435991A1 Use of aplidine for the treatment of pancreatic cancer |
| 07/14/2004 | EP1435990A1 Kahalalide compounds for use in cancer therapy |
| 07/14/2004 | EP1435989A1 Ptp1b inhibitors and ligands |
| 07/14/2004 | EP1435988A1 Improved use of antitumoral compound in cancer therapy |
| 07/14/2004 | EP1435987A1 Method and composition for treating immune complex associated disorders |
| 07/14/2004 | EP1435986A2 Igf-binding protein-derived peptide or small molecule |
| 07/14/2004 | EP1435985A2 Medicament containing activated antithrombin iii |
| 07/14/2004 | EP1435984A1 Use of histamine to treat liver disease |
| 07/14/2004 | EP1435981A2 Anti-tumor activity from reptile serum |
| 07/14/2004 | EP1435979A2 Methods for treating multiple sclerosis |
| 07/14/2004 | EP1435975A2 Methods of using 279, a human g protein-coupled receptor |
| 07/14/2004 | EP1435973A1 Coadministration of transport protein with conjugated cobalamin to deliver agents |
| 07/14/2004 | EP1435965A2 Pharmaceutical compositions and methods for treating cancer |
| 07/14/2004 | EP1435925A2 Gap junctions and edhf |
| 07/14/2004 | EP1435924A2 Therapeutic composition and use |
| 07/14/2004 | EP1435922A1 Use of a copolymer to produce a galenic form containing a peptide or a protein as active agent |
| 07/14/2004 | EP1435914A1 Stable galenic freeze-dried pharmaceutical preparation of recombined carbohydrate-binding polypeptides |
| 07/14/2004 | EP1435910A1 Novel cyclosporin analog microemulsion preconcentrates |
| 07/14/2004 | EP1435906A2 Method for producing biologically active products |
| 07/14/2004 | EP1435826A2 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 07/14/2004 | EP1372689B1 Use of ikk-beta inhibitors and method for discovery of said inhibitors |
| 07/14/2004 | EP1345979B1 Novel polyesters, method for producing the same and depot medicaments produced from these polyesters |
| 07/14/2004 | EP1313440A4 Dental products comprising bone growth enhancing peptide |
| 07/14/2004 | EP1248802B1 Soluble ctla4 mutant molecules and uses thereof |
| 07/14/2004 | EP1194033A4 Transgenically produced antithrombin iii and mutants thereof |
| 07/14/2004 | EP1083924B1 Glucagon-like peptide-1 (glp-1) improves beta-cell response to glucose in subjects with impaired glucose tolerance |
| 07/14/2004 | EP1082133B1 Stable pharmaceutical formulations for igf/igfbp |
| 07/14/2004 | EP1049482A4 Method of producing elastin, elastin-based biomaterials and tropoelastin materials |
| 07/14/2004 | EP1017823B1 Engineered protein kinases which can utilize modified nucleotide triphosphate substrates |
| 07/14/2004 | EP1009427A4 USE OF FACTOR XIIIa INHIBITORS TO TREAT ATHEROSCLEROSIS |
| 07/14/2004 | EP0948358B1 Stable liquid interferon formulations |
| 07/14/2004 | EP0825868B1 Prevention or treatment of alimentary tract damage due to chemotherapy or radiation |
| 07/14/2004 | EP0824588B1 Il-6 activity inhibitor |
| 07/14/2004 | EP0754227B1 Chimeric complement inhibitor proteins |
| 07/14/2004 | EP0749442B1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
| 07/14/2004 | EP0730601B1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
| 07/14/2004 | EP0604409B1 Oligonucleotide analogs for detecting and modulating rna activity and gene expression |
| 07/14/2004 | CN1512999A 2-{[N-(2-amino-3-(heteroaryl or aryl) propionyl)-aminoacyl]-amino}- alkylboronic acid derivatives |
| 07/14/2004 | CN1512998A Proteins producing altered immunogenic response and methods of making and using the same |
| 07/14/2004 | CN1512893A Use of antioxidant for treating and/or preventing surface ocular disorders |
| 07/14/2004 | CN1512892A Orally administering parathyroid hormone and calcitonin |
| 07/14/2004 | CN1512891A Epitope sequences |
| 07/14/2004 | CN1512890A HCG formulation |
| 07/14/2004 | CN1512888A Modified proteins, designer toxins and methosd of making thereof |
| 07/14/2004 | CN1512885A Pharmaceutical combinations |
| 07/14/2004 | CN1512876A Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation |
| 07/14/2004 | CN1512868A Methods of preventing UVB-induced skin damage |
| 07/14/2004 | CN1512845A Calorically dense liquid oral supplement |
| 07/14/2004 | CN1511958A System of T cell surface antigen peptide screening human tissue compatibility antigen (HLA) and its application in producing MHC-antigen peptide polymer |
| 07/14/2004 | CN1511952A Recombined glucokinase |
| 07/14/2004 | CN1511848A Branched chain polyethylene glycol-integrated int3erferon composition and preparation |
| 07/14/2004 | CN1511847A Ubiquitin-like molecule coming from human dendritic cell and its codnig sequence and use |
| 07/14/2004 | CN1511843A Novel cynthetic antibiotic peptide and its preparing method and use |
| 07/14/2004 | CN1511842A Rockfish insulin-like growth factor I gene and carrier containing said gene and recombined strain and its use |
| 07/14/2004 | CN1511841A Homoeotic box gene 9Brn-1 from quail and its use |
| 07/14/2004 | CN1511586A Oral digestible film and its preparing process and use |
| 07/14/2004 | CN1511585A Polyglycol-interferon water solution |
| 07/14/2004 | CN1157482C Compond with anti fungus activity and its preparing method |
| 07/14/2004 | CN1157409C Genetically engineered fish growth hormone and its use in aquatic product culture |
| 07/14/2004 | CN1157408C Agonist or antagonist of gluoprotein hormone activity existed in single-chain forms of glycoprotein hormone quartet |
| 07/14/2004 | CN1157407C Human interleukin-6 inhibitor |
| 07/14/2004 | CN1157406C Novel, ATP-sensitive potassium-channel proteins and genes for the same |
| 07/14/2004 | CN1157405C Preparation method of cholera toxin B sub unit |
| 07/14/2004 | CN1157232C Prepn of osteological material containing nano phase calcium phosphate, collagen and alginate |
| 07/14/2004 | CN1157226C Stable alpha-interferon preparation |
| 07/14/2004 | CN1157225C Lectin compositions and uses tehreof |
| 07/14/2004 | CN1157224C Novel amide derives. as growth hormone secretagogues |
| 07/14/2004 | CN1157223C Dolastatin-15 derivatives in combination with taxanes |
| 07/14/2004 | CN1157201C Composite non-opium medicine for dropping drugs |
| 07/13/2004 | USRE38556 Recombinant adeno viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias |
| 07/13/2004 | US6762296 Antitumor protein and corresponding gene sequence isolated from matsutake mushrooms |
| 07/13/2004 | US6762295 For the treatment or prevention of gastroduodenal disease associated heliobacter infections |
| 07/13/2004 | US6762290 Includes rna ligands that inhibit the interaction of a vegf receptor with vegf |
| 07/13/2004 | US6762286 Modified vitamin K-dependent polypeptides |
| 07/13/2004 | US6762284 Used for medical applications, including diagnosis and treatment cell growth disorders like restenosis and cancer |
| 07/13/2004 | US6762283 Caspase-8 interacting proteins |
| 07/13/2004 | US6762281 Process for preparing peptide derivatized oligomeric compounds |
| 07/13/2004 | US6762187 Heterocyclic nitrogen compounds used as enzyme inhibitors for prophylaxis of human immunodeficiency virus(hiv) |
| 07/13/2004 | US6762179 (2-arylamino-4-thiazole)pyrimidine compounds; useful for treating diabetes, alzheimer's disease, stroke, proliferative disorders, and asthma |
| 07/13/2004 | US6762176 Inhibiting no-synthase enzymes producing nitrogen monoxide and/or trapping reactive forms of oxygen; inhibit lipidic peroxidation |
| 07/13/2004 | US6762169 Improved transmembrane delivery of nucleosides conjugated to an arylpropionic acid ligand (ibuprofen) which has affinity for plasma protein albumin; antisense therapy |
| 07/13/2004 | US6762167 Methods for treating a patient undergoing chemotherapy |
| 07/13/2004 | US6762166 Complementary peptides for the proline-glycine-proline sequence as antagonists of polymorphonuclear leukocyte chemoattractants; treating alkali-injuried eyes |
| 07/13/2004 | US6762165 Snail venom; muscular disorders, central nervous system disorders, cardiovascular disorders |
| 07/13/2004 | US6762164 Use of 3-position cyclosporin derivatives for hair growth |
| 07/13/2004 | US6762158 Personal care compositions comprising liquid ester mixtures |
| 07/13/2004 | US6762045 Membrane derived caspase-3, compositions comprising the same and methods of use therefor |
| 07/13/2004 | US6762044 Disintegrins; metalloproteases; drug delivery; antithrombotic, antimetastatic agents |